Many familial aggregation studies have demonstrated a significant genetic contribution to blood pressure variation. First-degree relative correlations for systolic (SBP) or diastolic blood pressure (DBP) are typically in the range of 0. 1-0.3 (ref. 1). Correlations between monozygotic twins (0.5-0.8) vs. dizygotic twins (0.25-0.54) also indicate a substantial genetic contribution to blood pressure. 1-3 Heritability estimates for blood pressure across ethnicities range from ~15% to >50% (e.g., 30% in Indians, 4 33% in Taiwanese, 5 43-45% in Nigerians, 6 and 55-57% in Framingham, MA 7 ).
original contributions
Analysis of AGT in Large UGRP Pedigrees the original 47 Utah Centre d'Etude Polymorphisme Humain families that were initially ascertained for large sibships and a lack of disease phenotypes for linkage mapping studies. 15 A typical family in this study consists of 2 parents and an average of 8 siblings (range [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] . Most siblings, now in their 3rd or 4th decade, maintain independent households. These families were contacted again and extensively phenotyped for many qualitative and quantitative traits through the UGRP as previously described. 16 All participants provided written informed consent, and studies were conducted with University of Utah Institutional Review Board approval (IRB 6090-96).
Genotyping. Twenty-five common SNPs with allele frequencies >0.05 in Europeans were selected for genotyping. SNPs were assayed using the SNaPshot protocol according to the manufacturer's recommendations (Applied Biosystems, Foster City, CA). Genotypes were called using the GeneScan and Genotyper software packages (Applied Biosystems). Parental genotypes conformed to Hardy-Weinberg expectations. Missing genotypes in parents were inferred from offspring data where there was no ambiguity. Parental haplotypes were inferred from genotype data using fastPHASE. 17 Phenotyping. Resting SBP and DBP were measured as the first and fifth Korotkoff sounds by a standard auscultatory method. Eighty-five participants (20%) were hypertensive (measured BP ≥140/90 or previously diagnosed), and 18 of these reported using antihypertensive therapy. Fifty females reported using exogenous estrogen in any form. Body mass index (BMI), in kg/m 2 , was calculated from standard height and weight measurements. Venous blood samples were collected in the morning following an overnight fast. Plasma samples were prepared from blood and flash-frozen in liquid nitrogen. Plasma samples were stored at −80 °C until use.
Plasma AGT was measured by a competitive-binding enzyme immunoassay to angiotensin I. Previously flash-frozen plasma samples were thawed on ice. Each plasma sample (10 µl) was incubated with human renin (50 mmol/l sodium acetate (pH 6.5), 2 µg/ml 4-(2-aminoethyl) benzene sulfonyl fluoride, 0.002% 8-hydroxyquinoline, 5 mmol/l ethylenediaminetetraacetic acid, and 2.5 nmol/l recombinant human renin (Sigma, St Louis, MO) for 2 h at 37 °C to completely convert all plasma AGT to angiotensin I. After a 1,500-fold dilution in assay buffer, samples were incubated with polyclonal rabbit anti-angiotensin I and a biotin-labeled angiotensin I competitor. Reaction complexes were immobilized in a 96-well assay plate, and streptavidin-conjugated horseradish peroxidase was added. After washing, tetramethyl-benzidine dihydrochloride was added to each well. Oxidation of tetramethyl-benzidine dihydrochloride by horseradish peroxidase produces a dimeric colored product that was fixed by addition of 100 µl of 1N HCl and assayed using a spectrophotometer (450 nm). Horseradish peroxidase activity and color development are proportional to angiotensin I-biotin, allowing measurement of sample angiotensin I relative to standards. The quantity of sample angiotensin I is proportional to the quantity of AGT in a 1:1 molar ratio. All individuals were measured in triplicate. Effective linear measurement range was ~10-60 pg. Heat-denatured controls indicated no detectable plasma angiotensin I. Synthetic angiotensin I (Sigma) was also measured to provide an additional control across daily assays. Our average plasma AGT measurement (711 ng/ml) was modestly lower than reports using traditional radioimmunoassays, and this difference likely reflects minor differences in the standards and the inclusion of very few hypertensives in our sample. Immunoreagents and assay plates were obtained through Peninsula Laboratories (San Carlos, CA). The genotype and phenotype data are provided in Supplementary File 1.
Statistical analysis. The distribution of plasma AGT values in the UGRP families deviated from normality (P < 0.005, Anderson-Darling test) and was positively skewed (1.15). A Box-Cox power transformation was used to normalize the plasma AGT distribution (see Supplementary Figure S1 online). The transformation parameter, λ, was estimated using maximum likelihood (λ = −0.439). Plasma AGT values were then normalized as Y = ((X + c) λ − 1)/λ, where Y is the normalized estimate, X is measured plasma AGT, and c is a constant.
Inter-and intraclass correlations for plasma AGT, SBP, and DBP in the UGRP families were obtained using the FCOR algorithm in the S.A.G.E. 6.0 software package. 18 Briefly, a correlation (r xy ) between N pairs (x, y) of observed trait 19 Briefly, a maximum likelihood approach was used to estimate the total additive heritability of plasma AGT, SBP, and DBP over all pedigrees. Covariates of age, age 2 , sex, BMI, hypertensive status, use of antihypertensive medication, and self-reported estrogen use were tested individually and in combination. Only significant covariates (P < 0.1) were retained in the final model of heritability. After removing the influence of the significant covariates, we further parameterized the proportion of the total remaining variance attributable to each AGT SNP or AGT haplotype model, the remaining residual genetic variance, and the residual nongenetic variance. Identity-by-descent matrices were constructed for all pedigrees, and two-point linkage analysis between each SNP marker or haplotype group, and each quantitative trait was performed. The maximum logarithm of the odds (LOD) score was reported for each SNP and haplotype model for plasma AGT.
RESulTS
Plasma AGT levels, blood pressure, age, and BMI in individuals from 41 two-generation UGRP families are shown in Table 1 . Plasma AGT values were significantly higher in females than in males for the two major age categories (P < 0.002 parents, P < 0.0001 offspring; rank-sum test). Plasma AGT values were similar in male parents and male offspring but were significantly higher in female parents than in female offspring (P < 0.01; rank-sum test). As expected, SBP and BMI increased with age.
To test the hypothesis that plasma AGT is correlated among related individuals in the UGRP families, correlation coefficients among eight familial classes were calculated ( Table 2) . Plasma AGT values are significantly correlated among most classes of parent-offspring relationships. Correlations between parents and male offspring are higher than for parents and female offspring, and all intraclass plasma AGT correlations are significant and higher in males than in females. Brother-brother values show the strongest correlation. Spousal plasma AGT levels are correlated. This value is not significant but would likely reach significance with a larger sample size, suggesting modest environmental or shared household influences on plasma AGT levels.
SBP and DBP show significant correlation between parents and offspring (P < 0.01), and these correlations are generally higher than those between siblings. For each of the eight familial classes, correlations for plasma AGT exceed correlations for SBP or DBP. AGT, angiotensinogen; DBP, diastolic blood pressure; SBP, systolic blood pressure. *P < 0.05, **P < 0.01. original contributions
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The genetic and nongenetic variance components for plasma AGT and blood pressure traits are shown in Table 3 . The total additive genetic heritability for normalized plasma AGT levels in the 41 UGRP families is 0.74. Sex, a sex × age interaction term, and estrogen use are significant independent covariates for plasma AGT heritability (P < 10 −6 , P < 0.07, and P < 10 −4 , respectively). SBP and DBP also show significant heritability, and age, sex, BMI, hypertensive status, and antihypertensive medication are significant covariates. The heritability estimates for plasma AGT are two to three times higher than heritability estimates for blood pressure.
Heritability estimates for plasma AGT and blood pressure in the UGRP families differ by sex. The heritability of plasma AGT is 0.89 for male offspring and 0.53 for female offspring.
The heritability of SBP is 0.38 in male offspring and 0.17 in female offspring. The heritability of diastolic blood pressure is 0.29 in male offspring and 0.04 in female offspring.
To test the relationship between AGT genetic variation and plasma AGT levels, all individuals were genotyped for 25 SNPs spanning the AGT gene and promoter region (Figure 1) . We estimated the additive genetic heritability (h 2 ) and calculated a linkage score for each SNP with plasma AGT as a continuous variable over all 41 UGRP families ( Table 4) .
A maximum LOD score of 3.8 was obtained with marker rs943580, located immediately 3′ of the gene. The functional A-6G promoter SNP also produced a significant LOD score of 3.3, and an additional four markers between promoter SNP rs5051 (A-6G) and rs943580 (C12822T) produced significant original contributions
LOD scores (>3.0). The A-6G polymorphism is in strong linkage disequilibrium with rs943580. Marker rs3789670, however, is not in disequilibrium with the A-6G promoter variant, is in strong disequilibrium with four other low-frequency promoter SNPs, and yielded a LOD score of 3.3. These results suggest that there are multiple linkage blocks within the AGT gene (see Figure 1) . Markers with significant LOD scores produced locusattributable heritability estimates that approach the overall heritability estimate for plasma AGT. Promoter SNPs 5′ of rs5051 have lower LOD scores and lower marker-specific heritability estimates. These results demonstrate that AGT genetic variation accounts for a large percentage of the overall heritability of plasma AGT in the UGRP families.
Linkage and heritability were estimated for each AGT SNP and blood pressure as a quantitative trait. No LOD score for linkage of any AGT SNP to the quantitative traits of SBP or DBP exceeded 0.34. Additionally, correlations between plasma AGT, and SBP or DBP in the UGRP parents are low and nonsignificant (P > 0.9).
Finally, we tested complete AGT haplotypes for linkage to the quantitative trait of plasma AGT. Five common (frequency >0.05) and six minor AGT haplotypes occur in the parental generation. The LOD score using all 11 haplotypes over the 41 families was 2.9. In hypertensives of European ancestry, we found previously 14 that plasma AGT levels were best predicted by a three-way model in which common haplotypes H1/H2 produce lower plasma AGT levels, haplotype H4 contributes to higher plasma AGT levels, and other haplotypes have intermediate effects (Supplementary Figure S2 online) . We tested this and several other haplotype models for linkage. The three-way haplotype model produces the highest LOD score (5.1) in the UGRP families and a locus-attributable heritability estimate of 0.67. These results show that a three-way haplotype model using AGT haplotypes accounts for the genetic heritability of plasma AGT with little residual genetic variance and produces more significant linkage results than does any individual AGT SNP.
dISCuSSION
Our analysis shows that there is significant heritability for the quantitative trait of plasma AGT in the UGRP families. Other studies have also demonstrated a substantial genetic component influencing plasma AGT levels, but heritability estimates have varied by study and population. A large family study yielded high heritability estimates for native Nigerians (77%) but low estimates for African Americans (17%), and these differences were attributed to different environmental effects in these populations. 20 The highest heritability estimate reported for plasma AGT was 90% in Flemish adult male twins, though no significant heritability was found for female twin pairs. 11 Our plasma AGT heritability estimate of 74% overall is broadly consistent with previous studies, and our analyses suggest that a larger percentage of the genetic variation in plasma AGT levels can be attributed to variation in the AGT locus itself. In addition, sex, age, and exogenous estrogen account for ~14% of the total variance in plasma AGT values. original contributions
Analysis of AGT in Large UGRP Pedigrees
Our results also show higher correlations and higher heritability estimates for plasma AGT in males than in females. In this and other studies, plasma AGT values are higher and have a greater range and variance in females than in males. This sex difference may be influenced by an estrogen response element located in the promoter region of the AGT gene. 21 Exogenous hormone therapy may also alter AGT levels, possibly reducing correlations in females. 21, 22 Self-reported exogenous estrogen use was a significant covariate for plasma AGT and contributed directly to higher average plasma AGT levels for females in this study. Recent studies have shown gender differences in tissue plasminogen activator levels and a modest correlation between angiotensin II type I receptor variation in females. 23 The fact that sex and estrogen replacement therapy are also significant covariates in this and other studies suggests that these factors should be taken into account in future studies of AGT variation and plasma AGT levels.
A proportionate relationship between female waist circumference and plasma AGT in obese women has been reported, 24 but we found that normalized plasma AGT values were not significantly correlated with BMI and that BMI was not a significant covariate in the heritability estimate (P > 0.1). As expected, BMI accounted for a significant proportion of the variance of SBP and DBP.
In contrast to the high heritability of plasma AGT levels, heritability estimates for SBP and DBP were modest (0.26 and 0.16, respectively). These estimates are roughly concordant with heritability estimates of 0.28 (SBP) and 0.30 (DBP) based on initial clinical blood pressure measurements reported by the Framingham Heart Study Project; long-term (30-year average blood pressure) heritability estimates, however, were higher (SBP = 0.57 and DBP = 0.55). 7 Even though plasma AGT and blood pressure were significantly heritable in the UGRP families, there was no evidence for linkage between AGT SNPs and the quantitative estimates of SBP or DBP, nor were plasma AGT values significantly correlated with SBP or DBP values. This finding is consistent with a previous report showing that genetic variation at the α-adducin, AGT, angiotensin II type I receptor, and G-protein β3 loci has little influence on the observed heritability of SBP or DBP. 25 Large genome-wide case-control studies, however, will have considerably more power to detect associations of modest effect and may further reveal associations between genetic variation and essential hypertension.
Our results differ from those of a previous study that reported a positive significant correlation (r = 0.39) between plasma AGT levels and diastolic blood pressure. 26 The study included approximately equal numbers of unrelated male normotensive (274) and untreated hypertensive (300) individuals, with the latter group having 48% higher average plasma AGT. Only 20% of individuals in this study were hypertensive. Additionally, we recently reported that associations between AGT genetic variation and plasma AGT levels are significantly greater when hypertensive patients were sodium depleted. 14 Thus, positive associations between plasma AGT and blood pressure may be stronger in analyses that include large numbers of hypertensive individuals under controlled low-sodium conditions. Longitudinal studies, monitoring plasma AGT and progression to hypertensive status over time, are needed to further clarify the role of AGT in the development of essential hypertension.
In a previous study of unrelated hypertensive cases and controls, 14 we found that a three-way haplotype model better explains the relationship between AGT genetic variation and plasma AGT levels than do individual SNPs. In the model, common AGT haplotypes H1/H2 were associated with lower plasma AGT levels, H4 with higher AGT levels, and other common haplotypes had intermediate effects on plasma AGT (see Supplementary Figure S2 online). The present study, based on an independent cohort of predominantly normotensive individuals in large families, also demonstrates that the same haplotype model accounts for plasma AGT variation better than do single SNPs. Additional studies, in larger cohorts and differing ancestral backgrounds, will help to establish the generality of this finding.
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